With increasing pricing pressures in a therapeutic area which has seen many recent drug approvals, diabetes drug developers are seeking to enhance their clinical development and portfolio. By leveraging Continuous Glucose Monitoring (CGM), sponsors conducting trials in diabetes as well as other indications have the potential to enhance patient safety, accelerate clinical development and increase commercial value.
QuintilesIMS, in collaboration with key CGM opinion leaders, presented 'Capturing Continuous Glucose Monitoring Advantages' webinar to discuss the advantages of using CGM in your clinical trials.
The webinar showcases:
- Expert insights from QuintilesIMS’s Diabetes Center of Excellence
- Firsthand case studies on how using CGM devices can help increase commercial value
- Opportunities for CGM to accelerate clinical trials
Understand how CGM captures near real-time glycemic data that can help enhance patient safety, accelerate clinical development and increase commercial value.Watch webinar now